English |
Title | Plasma milrinone concentrations during continuous hemodiafiltration : A case report |
Subtitle | |
Authors | Ryu Okutani, Yoshiteru Yoshioka, Ryusuke Ueki, Chikara Tashiro |
Authors(kana) | |
Organization | Intensive Care Unit, Hyogo Medical College Hospital |
Journal | Circulation Control |
Volume | 22 |
Number | 2 |
Page | 132-134 |
Year/Month | 2001/ |
Article | Report |
Publisher | Japan Society of Circulation Control |
Abstract | Milrinone enhances myocardial contraction and has vasodilating activity by inhibiting phosphodiesterase (PDE) in the myocardial cells, increasing cellular cAMP and inducing increased Ca2+ inflow 1,2). Some patients with severe cardiac failure require continuous hemodiafiltration (CHDF) due to complicated renal failure. We report a case in which CHDF was performed during the administration of milrinone after open heart surgery and the plasma concentration of the drug was measured. |
Practice | Basic medicine |
Keywords | Plasma milrinone concentration, Renal dysfunction, Continuous hemodiafiltration |